Xencor | XNCR - Stock



Xencor reported $0 in Stock for its fiscal quarter ending in June of 2020.


Stock Change Date
AbbVie USD 4.53B 345M Mar/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Amgen USD 6.58B 146M Jun/2025
Arrowhead Research USD -173085000 173.08M Dec/2024
AstraZeneca USD 6.47B 583M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Cytokinetics 0 0 Dec/2023
GlaxoSmithKline GBP 6.07B 72M Jun/2025
J&J USD 12.66B 215M Mar/2025
MacroGenics USD 9.28M 9.28M Jun/2025
Merck USD 6.6B 405M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Xencor USD 0 0 Jun/2020